Clinical Trial Update: Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Biological Drug Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate and a First Biological Drug [Phase 4]

View source ↗

Summary

Phase 4 trial in rheumatoid arthritis evaluates how methotrexate erythrocyte polyglutamate levels relate to concentrations of a first biological drug and to cli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• First biological drug (unnamed)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED